Canaccord Genuity Starts Shockwave Medical (SWAV) at Buy

Go back to Canaccord Genuity Starts Shockwave Medical (SWAV) at Buy

BofA/Merrill Lynch Starts Shockwave Medical (SWAV) at Neutral

April 1, 2019 6:27 AM UTC

BofA/Merrill Lynch initiates coverage on Shockwave Medical (NASDAQ: SWAV) with a Neutral rating and a price target of $37.00.

For an analyst ratings summary and ratings history on Shockwave Medical click here. For more ratings news on Shockwave Medical click here.

Shares of Shockwave Medical closed at $33.47 yesterday.

... More

Wells Fargo Starts Shockwave Medical (SWAV) at Market Perform

April 1, 2019 3:47 AM UTC

Wells Fargo initiates coverage on Shockwave Medical (NASDAQ: SWAV) with a Market Perform rating.

For an analyst ratings summary and ratings history on Shockwave Medical click here. For more ratings news on Shockwave Medical click here.

Shares of Shockwave Medical closed at $33.47 yesterday.

... More

Morgan Stanley Starts Shockwave Medical (SWAV) at Equalweight

April 1, 2019 3:39 AM UTC

Morgan Stanley initiates coverage on Shockwave Medical (NASDAQ: SWAV) with a Equalweight rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Shockwave Medical click here. For more ratings news on Shockwave Medical click here.

Shares of Shockwave Medical closed at $33.47 yesterday.

... More